Original Research

Published on 17 Jan 2024

The prevalence of off-label use and supratherapeutic blood levels of outpatient psychotropic medication in suicidal adolescents

in Psychopharmacology

Isabel Hach
Thomas Bertsch
Patrick Nonell

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1240681

285 views

Editorial

Accepted on 16 Jan 2024

Editorial: Case Reports in Psychopharmacology -Adverse Events of Psychotropics, Treatment Optimization and Collaborate including Clinical Pharmacist

in Psychopharmacology

Matej Stuhec
Patricia Di Ciano

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1364711

Clinical Trial

Published on 16 Jan 2024

Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial

in Psychopharmacology

Seyed Shahab Banihashem
Seyedeh Mahsa Mofatioshieh
Reyhaneh Rastegar
Amir Sadeghi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1297231

232 views

Original Research

Published on 11 Jan 2024

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial

in Psychopharmacology

Ellen James
David Erritzoe
Tiffanie Benway
Zelah Joel
Christopher Timmermann
Meghan Good
Claudio Agnorelli
Brandon M. Weiss
Tommaso Barba
Graham Campbell

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1305796

513 views

Brief Research Report

Published on 11 Jan 2024

Prescribed psychotropic medication patterns among treated Foster Care enrollees: a single institution study

in Psychopharmacology

Celica Glenn Cosme
Nathan O. Rudig
Philip J. Borsellino
Deanna Chea
Reese I. Krider
Lisa Durette

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1278233

267 views

Review

Published on 10 Jan 2024

A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders

in Psychopharmacology

Colin J. McArdle
Alana A. Arnone
Chelcie F. Heaney
Kimberly F. Raab-Graham

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1296527

334 views

Original Research

Published on 08 Jan 2024

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin

in Psychopharmacology

Nathan T. Jones
Laura Wagner
Molly C. Pellitteri Hahn
Cameron O. Scarlett
Cody J. Wenthur

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1303365

1,077 views

Original Research

Published on 08 Jan 2024

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

in Psychopharmacology

Helena D. Aicher
Michael J. Mueller
Dario A. Dornbierer
Dila Suay
Claudius Elsner
Ilhui Wicki
Daniel Meling
Luzia Caflisch
Alexandra Hempe
Camilla Steinhart

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1302559

1,286 views

Systematic Review

Accepted on 05 Jan 2024

Keeping the Promise: A Critique of the Current State of Microdosing Research

in Psychopharmacology

Rotem Petranker
Thomas Anderson
Emily C Fewster
Youval Aberman
Marik Hazan
Michael Gaffery
Paul Seli

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1217102

Hypothesis and Theory

Accepted on 05 Jan 2024

Ketamine Assisted Psychotherapy, Psychedelic Methodologies and The Impregnable Value of the Subjective—A New and Evolving Ap-proach

in Psychopharmacology

Philip Wolfson
Phil Wolfson
Gita Vaid

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1209419

Perspective

Published on 05 Jan 2024

Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

in Psychopharmacology

Tobias Banaschewski
Alexander Häge
Sarah Hohmann
Konstantin Mechler

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1289157

907 views

Original Research

Accepted on 04 Jan 2024

Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety

in Psychopharmacology

Jan Sarlon
Johannes Hauser
Timur Liwinski
Annette Beatrix Bruehl
Undine Emmi Lang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1327598

Case Report

Accepted on 02 Jan 2024

Case Report: Adult with Bipolar Disorder and Autism treated with Ketamine Assisted Psychotherapy

in Psychopharmacology

Christopher Harris
Becky Jones
Kathryn Walker
Meredith S. Berry

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322679

141 views

Case Report

Published on 27 Dec 2023

Clinical pharmacist interventions in the transition of care in a mental health hospital: case reports focused on the medication reconciliation process

in Psychopharmacology

Matej Stuhec
Borjanka Batinic

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1263464

720 views

Original Research

Published on 12 Dec 2023

Trends in antipsychotic use among children and adolescents in Germany: a study using 2011–2020 nationwide outpatient claims data

in Psychopharmacology

Michael Dörks
Christian J. Bachmann
Maike Below
Falk Hoffmann
Lena M. Paschke
Oliver Scholle

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1264047

989 views

Mini Review

Published on 08 Dec 2023

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management

in Psychopharmacology

Alina Wilkowska
Wiesław Jerzy Cubała

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1322752

801 views

Navigation group

Articles

The prevalence of off-label use and supratherapeutic blood levels of outpatient psychotropic medication in suicidal adolescents

Editorial: Case Reports in Psychopharmacology -Adverse Events of Psychotropics, Treatment Optimization and Collaborate including Clinical Pharmacist

Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial

Prescribed psychotropic medication patterns among treated Foster Care enrollees: a single institution study

A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Keeping the Promise: A Critique of the Current State of Microdosing Research

Ketamine Assisted Psychotherapy, Psychedelic Methodologies and The Impregnable Value of the Subjective—A New and Evolving Ap-proach

Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety

Case Report: Adult with Bipolar Disorder and Autism treated with Ketamine Assisted Psychotherapy

Clinical pharmacist interventions in the transition of care in a mental health hospital: case reports focused on the medication reconciliation process

Trends in antipsychotic use among children and adolescents in Germany: a study using 2011–2020 nationwide outpatient claims data

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management